Literature DB >> 17873347

Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective.

Cathrin Brisken1, Stephan Duss.   

Abstract

The mammary gland is a unique organ in that it undergoes most of its development after birth under the control of systemic hormones. Whereas in most other organs stem cells divide in response to local stimuli, to replace lost cells, in the mammary gland large numbers of cells need to be generated at specific times during puberty, estrous cycles and pregnancy to generate new tissue structures. This puts special demands on the mammary stem cells and requires coordination of local events with systemic needs. Our aim is to understand how the female reproductive hormones control mammary gland development and influence tumorigenesis. We have shown that steroid hormones act in a paracrine fashion in the mammary gland delegating different functions to locally produced factors. These in turn, affect cell-cell interactions that result in changes of cell behavior required for morphogenesis and differentiation. Here, we discuss how these hormonally regulated paracrine interactions may impinge on stem cells and the stem cell niche and how this integration of signals adds extra levels of complexity to current mammary stem cell models. We propose a model whereby the stem cell niches change depending on the developmental stages and the hormonal milieu. According to this model, repeated hormone stimulation of stem cells and their niches in the course of menstrual cycles may be an important early event in breast carcinogenesis and may explain the conundrum why breast cancer risk increases with the number of menstrual cycles experienced prior to a first pregnancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873347     DOI: 10.1007/s12015-007-0019-1

Source DB:  PubMed          Journal:  Stem Cell Rev        ISSN: 1550-8943            Impact factor:   5.739


  60 in total

1.  IGF-2 is a mediator of prolactin-induced morphogenesis in the breast.

Authors:  Cathrin Brisken; Ayyakkannu Ayyannan; Cuc Nguyen; Anna Heineman; Ferenc Reinhardt; Jian Tan; S K Dey; G Paolo Dotto; Robert A Weinberg; Tian Jan
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

Review 2.  Cancer stem cells: lessons from leukemia.

Authors:  Jean C Y Wang; John E Dick
Journal:  Trends Cell Biol       Date:  2005-09       Impact factor: 20.808

3.  A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.

Authors:  W P Bocchinfuso; W P Hively; J F Couse; H E Varmus; K S Korach
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

Review 4.  Stem cells in mammary development and carcinogenesis: implications for prevention and treatment.

Authors:  Gabriela Dontu; Suling Liu; Max S Wicha
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

5.  IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development.

Authors:  Y Cao; G Bonizzi; T N Seagroves; F R Greten; R Johnson; E V Schmidt; M Karin
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

6.  Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland.

Authors:  Sonia Mallepell; Andrée Krust; Pierre Chambon; Cathrin Brisken
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-01       Impact factor: 11.205

7.  Steroid hormone receptor status of mouse mammary stem cells.

Authors:  Marie-Liesse Asselin-Labat; Mark Shackleton; John Stingl; François Vaillant; Natasha C Forrest; Connie J Eaves; Jane E Visvader; Geoffrey J Lindeman
Journal:  J Natl Cancer Inst       Date:  2006-07-19       Impact factor: 13.506

8.  Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis.

Authors:  Emily Y Chu; Julie Hens; Thomas Andl; Alladin Kairo; Terry P Yamaguchi; Cathrin Brisken; Adam Glick; John J Wysolmerski; Sarah E Millar
Journal:  Development       Date:  2004-09-01       Impact factor: 6.868

9.  Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo.

Authors:  Arnaud André Mailleux; Bradley Spencer-Dene; Christian Dillon; Delphine Ndiaye; Catherine Savona-Baron; Nobuyuki Itoh; Shigeaki Kato; Clive Dickson; Jean Paul Thiery; Saverio Bellusci
Journal:  Development       Date:  2002-01       Impact factor: 6.868

10.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Kyle W Jackson; Erin McNicholas; Mari J Kawamura; Wissam M Abdallah; Max S Wicha
Journal:  Breast Cancer Res       Date:  2004-08-16       Impact factor: 6.466

View more
  35 in total

Review 1.  The normal microenvironment directs mammary gland development.

Authors:  Erin J McCave; Cheryl A P Cass; Karen J L Burg; Brian W Booth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-09-08       Impact factor: 2.673

2.  Long-term cultures of stem/progenitor cells from lobular and ductal breast carcinomas under non-adherent conditions.

Authors:  Agostina Nardone; Sara Corvigno; Annalisa Brescia; Daniel D'Andrea; Gennaro Limite; Bianca Maria Veneziani
Journal:  Cytotechnology       Date:  2010-12-28       Impact factor: 2.058

3.  Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.

Authors:  Christine M Fillmore; Piyush B Gupta; Jenny A Rudnick; Silvia Caballero; Patricia J Keller; Eric S Lander; Charlotte Kuperwasser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

4.  Netrin-1 can affect morphogenesis and differentiation of the mouse mammary gland.

Authors:  Luigi Strizzi; Mario Mancino; Caterina Bianco; Ahmed Raafat; Monica Gonzales; Brian W Booth; Kazuhide Watanabe; Tadahiro Nagaoka; David L Mack; Beatrice Howard; Robert Callahan; Gilbert H Smith; David S Salomon
Journal:  J Cell Physiol       Date:  2008-09       Impact factor: 6.384

Review 5.  Importance of the stem cell microenvironment for ophthalmological cell-based therapy.

Authors:  Peng-Xia Wan; Bo-Wen Wang; Zhi-Chong Wang
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

6.  Progesterone induces adult mammary stem cell expansion.

Authors:  Purna A Joshi; Hartland W Jackson; Alexander G Beristain; Marco A Di Grappa; Patricia A Mote; Christine L Clarke; John Stingl; Paul D Waterhouse; Rama Khokha
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

7.  Leptin and Adiponectin Modulate the Self-renewal of Normal Human Breast Epithelial Stem Cells.

Authors:  Raymond M Esper; Michael Dame; Shannon McClintock; Peter R Holt; Andrew J Dannenberg; Max S Wicha; Dean E Brenner
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-20

8.  CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.

Authors:  Christophe Ginestier; Suling Liu; Mark E Diebel; Hasan Korkaya; Ming Luo; Marty Brown; Julien Wicinski; Olivier Cabaud; Emmanuelle Charafe-Jauffret; Daniel Birnbaum; Jun-Lin Guan; Gabriela Dontu; Max S Wicha
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

9.  Human milk protein production in xenografts of genetically engineered bovine mammary epithelial stem cells.

Authors:  Eugenio Martignani; Peter Eirew; Paolo Accornero; Connie J Eaves; Mario Baratta
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

10.  The controversial clinicobiological role of breast cancer stem cells.

Authors:  Claudia Casarsa; Saro Oriana; Danila Coradini
Journal:  J Oncol       Date:  2009-03-19       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.